Conversion Privilege

Conversion privilege in insurance refers to the right of an individual to convert their group insurance policy to an individual policy, without the need to undergo medical underwriting or provide evidence of insurability. This privilege is typically provided to individuals who are covered under a group insurance plan, such as employees of a company or members of an association.

Here are some key features of conversion privilege in insurance:

• Group insurance coverage: Conversion privilege is typically offered as part of a group insurance policy, such as a group life or health insurance policy.

• Eligibility: Individuals who are covered under the group insurance policy may be eligible for conversion privilege. There may be specific eligibility criteria, such as the duration of the coverage period or the reason for termination of the group coverage.

• Time limit: Conversion privilege is usually subject to a time limit, which means that the individual must convert their policy within a specified period of time after the termination of the group coverage.

• No medical underwriting: One of the key benefits of conversion privilege is that the individual does not have to undergo medical underwriting or provide evidence of insurability. This means that they can obtain an individual policy even if they have a pre-existing medical condition.

• Premiums: The premiums for the individual policy may be higher than those for the group policy, as the individual policy is based on the individual's age, health, and other factors.

For example, an employee who is covered under a group life insurance policy may be eligible for conversion privilege if their employment is terminated. If the employee exercises their conversion privilege, they can convert their group life insurance policy to an individual life insurance policy without the need for medical underwriting. The individual policy may have higher premiums than the group policy, but it provides the employee with continued coverage.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.